GeneralConnection.com ➔ Dictionary
Dictionary Search

dosed

Synonyms

Adjective

1. treated

Usage
First participant dosed in Phase 2a trial of CSTI-500 for PWS - Prader-Willi Syndrome News
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis - Ophthalmology Times
Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board - PR Newswire
Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development - Yahoo Finance Singapore
First participant dosed in pioneering neural stem cell trial for Huntington’s disease - HDBuzz
Atom Therapeutics Announces First Patient Dosed in China Phase 3 Clinical Trial of Lingdolinurad (ABP-671) for Chronic Gout - BioSpace
Verrica Pharmaceuticals Announces First U.S. Patient Dosed - GlobeNewswire
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction - Business Wire
First patient dosed in Deciphera’s Phase III INTREPID study - Clinical Trials Arena
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis - Neurology® Journals
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial - NTB Kommunikasjon
First Huntington’s patient dosed in large trial of oral therapy votoplam - huntingtonsdiseasenews.com
First Patient Dosed with Azenosertib in Aspenova Phase III Trial for Treatment of Ovarian Cancer - Applied Clinical Trials Online
CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease - CytoDyn Inc.
First Participant Dosed in AskBio Phase 1/Phase 2 Gene Therapy Trial of AB-1009 for Late-Onset Pompe Disease (LOPD) - Bayer
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 (CAN-004) for Mitigation of Cannabis Withdrawal Symptoms in Patients with Cannabis Use Disorder - PR Newswire
Deciphera Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera - BioSpace
First patient dosed in CatalYm’s Phase IIb visugromab trial - Clinical Trials Arena
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody - PR Newswire
AvenCell Therapeutics Announces First Patient Dosed in Phase I QUADvance Study with AVC-203, a Novel Allogeneic CD19/CD20 Dual-Targeting CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-Cell Malignancies - PR Newswire
Dosed - Dosed | OFFICIAL TRAILER [HD] - IMDb
Ventus Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of VENT-03, a Novel Small Molecule cGAS Inhibitor, in Patients with Lupus - Ventus Therapeutics
CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer - CytoDyn Inc.
First patient dosed in Merck’s Phase III PROCEADE-CRC-03 trial for mCRC - Clinical Trials Arena
First patient dosed in phase I/II trial of complement-targeting gene therapy for geographic atrophy - Ophthalmology Times
GEMMABio Announces First Patient Dosed in CHARISMA Trial of GB221, Investigational Next‑Generation Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA1) - PR Newswire
GentiBio Announces First Participant Dosed in POLARIS Phase 1 Clinical Trial of GNTI-122 in Recently Diagnosed Type 1 Diabetes - PR Newswire
Unravel Biosciences Announces First Patient Dosed in RVL-001 Proof of Concept Studies for Rett Syndrome and Pitt Hopkins Syndrome - Business Wire
First Patient Dosed in JANX014 Trial in Metastatic CRPC - Targeted Oncology
BioAge Labs Announces First Participant Dosed in QUELL-CV, - GlobeNewswire
First patient dosed in Newleos’ Phase Ib trial of NTX-2001 - Clinical Trials Arena
Quetzal Therapeutics Announces First Patient Dosed in Phase - GlobeNewswire
First Patient Dosed in VIR-5500 T-Cell Engager Trial in Metastatic Prostate Cancer - Targeted Oncology
Repertoire Immune Medicines Announces First Participant Dosed in Phase 1/2 Trial of RPTR-1-201, a T Cell-Targeted Immune Medicine for Advanced Solid Tumors - PR Newswire
Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-1617, a Potential First-in-Class ADC, in Patients with Advanced Solid Tumors - Business Wire
Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome - Biogen
Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies - Yahoo Finance
Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies - GlobeNewswire
First patient dosed with CRISPR HBV silencer - CRISPR Medicine News
GT Biopharma Announces First Patient Dosed in Phase 1 Trial - GlobeNewswire
FibroBiologics Announces First Patients Dosed in Phase 1/2 - GlobeNewswire
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study - PR Newswire
A2B543: First Patient Dosed in Arm 2 of EVEREST-2 Study for Solid Tumors - Targeted Oncology
Iterion Therapeutics Announces First Patient Dosed in Clinical Study of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, in Relapsed/Refractory Osteosarcoma - PR Newswire
Evaluation of Initial Weight-Based Tacrolimus Dosing After Allogeneic Hematopoietic Stem Cell Transplant - Journal of Hematology Oncology Pharmacy
Dosing, duration, and timing controversies in determining immune checkpoint inhibitor dosing regimens - Nature
Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial - GlobeNewswire
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic Cancer - PR Newswire
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE - GlobeNewswire
Biotheryx Announces First Patient Dosed in the Dose Expansion Phase of BTX-9341-101 for the Treatment of HR+/HER2- Breast Cancer - PR Newswire
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies - GlobeNewswire
First Patient Dosed in Pivotal Phase 3 Study of TLX591-Px (Illuccix®) for Prostate Cancer Imaging in Japanese Patients - PR Newswire
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder - Business Wire
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - BioSpace
Crystalys Therapeutics Expands Phase 3 RUBY Study With First Patients Dosed at European Sites - PR Newswire
iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson’s and First Enrollment in China’s Randomized MSA Trial for NouvNeu004 - Fierce Biotech
GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder - PR Newswire
Milestone Alert: First Patient Dosed in Phase 3 Trial of Orelabrutinib for SLE - The Dermatology Digest
Hinge Bio Announces First Subject Dosed in Phase 1 Trial of - GlobeNewswire
Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014 - Business Wire
GlycoNex Announces Last Patient Dosed in Phase 3 Trial of SPD8, a Denosumab Biosimilar for Osteoporosis - PR Newswire
AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD) - Business Wire
MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness - Yahoo Finance
Kali Therapeutics Announces First Patient Dosed in Phase 1a Clinical Trial of KT501 for Rheumatoid Arthritis - BioSpace
FDA approves extended dosing intervals up to 20 weeks for EYLEA HD in wAMD and DME - Ophthalmology Times
Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies - Yahoo Finance
Kestrel Therapeutics Announces First Patient Dosed in the - GlobeNewswire
Neomorph Announces First Patient Dosed in Phase 1/2 Trial - GlobeNewswire
Development and validation of a machine learning model for individualised meropenem dosing in CRRT patients - Nature
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents - Business Wire
HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001, an Investigational Precision Cellular Reprogramming Therapy for Cardiac Fibrosis - Business Wire
AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab - PR Newswire
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria - Business Wire
Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy - GlobeNewswire
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas - PR Newswire
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer - Business Wire
First Patient Dosed in Phase 2 Trial of Small Interfering RNA Agent for VTE Prophylaxis - Docwire News
Calcitonin Dosing for Hypercalcemia of Malignancy - Journal of Hematology Oncology Pharmacy
Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer - Yahoo Finance
Dosed (2018) - IMDb
FDA Approves Once-Monthly Dosing Schedule for Amivantamab and Hyaluronidase-lpuj - The ASCO Post
MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001 - BioSpace
Vima Therapeutics Announces First Dystonia Patient Dosed in - GlobeNewswire
First Patients Dosed with Cabaletta Bio’s Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform - Business Wire
Milestone Alert: First Patient Dosed in Phase 3 Study of YCANTH for Common Warts - The Dermatology Digest
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN - Dermatology Times
Sapu Nano Announces First Patient Dosed in Phase 1b Trial - GlobeNewswire
First ALS patient dosed in study of experimental gene therapy VTx-002 - ALS News Today
Spot-on phage therapy: stable formulations, smarter dosing for topical phage application - Frontiers
Zenas BioPharma Announces First Subject Dosed in Phase 1 - GlobeNewswire
Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain - Yahoo Finance
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) - Business Wire
Subgroup analysis of genotype guided vs traditional warfarin dosing in Asian patients from an open label randomized trial | Scientific Reports - Nature
iVeena Delivery Systems Announces First Patient Dosed in Phase 1 Study of IVMED-85 in Healthy Adult Volunteers - Business Wire
Biosplice Therapeutics Announces First Patient Dosed in Investigator‑Initiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD Platinum‑Resistant Ovarian Cancer - GlobeNewswire
Effects of higher caffeine dosing on rates of bronchopulmonary dysplasia and neurodevelopmental outcomes - Nature
Dr Gesiotto on Optimal Ponatinib Dosing Strategies in CP-CML - OncLive
Palvella Therapeutics Announces First Patients Dosed in - GlobeNewswire
First patient dosed in trial of EN-374 to treat X-linked chronic granulomatous disease - Contemporary Pediatrics
Theolytics announces first patient dosed in the Octopod‑IP trial - PharmaTimes
Foreign Language Equivalents
Foreign Language Equivalents of 'dosed'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
odsed,   dossed,   osed,   ddosed,   dosd,   doesd,   dised,   fosed,   dosde,   doses,   doded,   dpsed,   doseed,   dsed,   dosrd,   dosef,   doosed,   dose,   sosed,   dsoed,   doswd,   doaed,   dosedd,   doed
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z